Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring-guided risperidone dosing in children and adolescents with autism spectrum disorder
NL-OMON23089Recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of risperidone in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Erasmus MC. Started Nov 2021; status: recruiting.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON23089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23089.